Clinical trial

Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention…

NCT00050622 · Florida International University, Other · Completed

Key facts

NCT number NCT00050622
Title Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
Official title ADHD Treatment: Comparative and Combined Dosage Effects
Lead sponsor Florida International University, Other
Collaborators National Institute of Mental Health (NIMH) NIH
Status Completed
Study type Interventional
Conditions Attention Deficit Disorder With Hyperactivity
Intervention type Behavioral, Drug
Interventions Methylphenidate 0.15 mg/kg, Low-Intensity BMOD, Methylphenidate 0.3 mg/kg, Placebo, Methylphenidate 0.6 mg/kg, High Intensity BMOD
Enrollment 154
Start date Sep 1, 2001
Primary completion Aug 1, 2004
Completion Jun 1, 2005
First posted Dec 17, 2002
Last update posted Sep 30, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies